{"disease":{"id":"purpura-thrombocytopaenic-idiopathic","name":"purpura thrombocytopaenic idiopathic"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01416311","title":"Drug Use Investigation for REVOLADE (ITP)","phase":"","overall_status":"COMPLETED","enrollment_count":5797,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT00908037","title":"Efficacy and Safety Study of Eltrombopag in Pediatric Patients With Thrombocytopenia From Chronic Idiopathic Thrombocytopenic Purpura (ITP)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":82,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT01072162","title":"Relative Bioavailibilty for Pediatric Powder for Suspension (PfOS) Formulation and Food Effect","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT00688272","title":"Study In Healthy Subjects To Evaluate The Photo-Irritant Potential Of Eltrombopag","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT00359463","title":"Study Of Eltrombopag in Healthy Subjects and Volunteers With Mild, Moderate or Severe Hepatic Impairment","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT00442871","title":"Study Of SB-497115 in Healthy Subjects and Subjects With Mild, Moderate or Severe Renal Impairment","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":29,"lead_sponsor_name":"GlaxoSmithKline","has_results":false}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}